Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator

INTRODUCTION: In phase-3 clinical trials, the interleukin (IL-1) blocker, rilonacept (IL-1 Trap), demonstrated efficacy for gout flare prevention during initiation of urate-lowering therapy. This trial evaluated rilonacept added to a standard-of-care, indomethacin, for treatment of acute gout flares...

Descripción completa

Detalles Bibliográficos
Autores principales: Terkeltaub, Robert A, Schumacher, H Ralph, Carter, John D, Baraf, Herbert SB, Evans, Robert R, Wang, Jian, King-Davis, Shirletta, Weinstein, Steven P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672764/
https://www.ncbi.nlm.nih.gov/pubmed/23375025
http://dx.doi.org/10.1186/ar4159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672764/
https://www.ncbi.nlm.nih.gov/pubmed/23375025
http://dx.doi.org/10.1186/ar4159

Ejemplares similares